ICMR to conduct trials of indigenously developed Zika vaccine Industry-Economic Times — November 18, 2018 comments off ICMR will undertake phase-II trial of the vaccine to establish the efficacy and safety of the vaccine along with its adverse effects.
ICMR will undertake phase-II trial of the vaccine to establish the efficacy and safety of the vaccine along with its adverse effects.